RLLVF (Relevium Technologies) Research & Development: $0.00 Mil (TTM As of Mar. 2022)


What is Relevium Technologies Research & Development?

Relevium Technologies RLLVF -99.98% Research & Development is $0.00 Mil as of Mar. 2022.

Research & Development is the aggregate amount of research and development expenses during the year. Relevium Technologies's Research & Development for the three months ended in Mar. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2022 was $0.00 Mil.

Relevium Technologies  (OTCPK:RLLVF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Relevium Technologies Research & Development Related Terms

Relevium Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Relevium Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Relevium Technologies Research & Development Chart

Relevium Technologies Annual Data
Trend Dec12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Relevium Technologies Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Relevium Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Relevium Technologies (RLLVF) has a Research & Development of $0.00 Mil as of Mar. 2022. Research and development expense is the total cost for research and development activities. View historical data on Relevium Technologies and its competitors.
Is Relevium Technologies' Research & Development too high?
Relevium Technologies' current Research & Development is $0.00 Mil.
How does Relevium Technologies' Research & Development compare to HEWA and SSY?
Relevium Technologies' Research & Development of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Relevium Technologies and its competitors. Relevium Technologies's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Relevium Technologies stock overvalued right now?
Relevium Technologies (RLLVF) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Relevium Technologies (RLLVF), the current Research & Development is $0.00 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Relevium Technologies Business Description

Address 1000 Sherbrooke Street West, Suite 2700, Montreal, QC, CAN, H3A 3G4
Relevium Technologies Inc is a Canada based company operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition, and operations of brands and businesses in the health and wellness markets including medical cannabis. Its operating segment includes Consumer Packaged Goods (CPG); Pediatric Biopharma and Corporate. The company generates maximum revenue from Consumer Packaged Goods segment.